Hydralazine diseaseT88.8

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 23.12.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Symptoms of disease after prolonged treatment with hydrazinophthalazine (lowering blood pressure) in 8-10% of cases.

Clinical featuresThis section has been translated automatically.

Image of systemic lupus erythematosus with transient erythema, urticarial itchy eruptions, punctiform hyperkeratosis, especially in the face and hands. Swelling of lymph nodes, splenomegaly, pericarditis, pleuritis, atypical pneumonia, kidney involvement.

LaboratoryThis section has been translated automatically.

Albuminuria, hematuria, cylinduria, leukopenia, gamma globulinemia, ANA positive. See also pseudo-SLE syndrome.

Authors

Last updated on: 23.12.2020

Author: Prof. Dr. med. Peter Altmeyer